Uni- yes, you are right about this year. So the question is peak sale. $1 b is great. Wish i can get more info such as target population and usage assumption.
If they can't grow b&l, it is really terrible sign. I mean they can't hike drug prices anymore. All the overpaid assets such as addyi.... How do they pay back their debts.....
including BMO today. Oh man, this list is growing each day.
yes, the street and wells fargo are negative.
But Zacks, M. fool, JP Morgan, Barclays, Mizuho, Nomura, CIBC, Piper Jaffray,
Canaccord Genuity, RBC Capital Mkts, TD Securities are all negative.
Did not remember a positive article about VRX recently?
Almost all the analysts are negative on VRX. Is this a simple truth or they have agenda?
Here is the change I can find ( there maybe more):
I don't think it is final. Just some update in process.
Patients will undergo a 3 week screening period followed by daily dosing of 4.5 g sodium oxybate for 1 week, 6.0 g sodium oxybate for 2 weeks, 7.5 g sodium oxybate for 5 weeks, and 9.0 g sodium oxybate for 5 weeks. Medication will be given orally at bedtime. Patients will undergo a 1 week follow up period
Patients will undergo a screening period and will then be titrated to the following daily doses: 4.5 g sodium oxybate, 6.0 g sodium oxybate, 7.5 g sodium oxybate, and 9.0 g sodium oxybate.